The Effectiveness and Value of Esketamine for the Management of Treatment-Resistant Depression.

Agboola F, Atlas SJ, Touchette DR, Fazioli K, Pearson SD

Open source

DOI
10.18553/jmcp.2020.26.1.16
Published
2020 Jan
Container
Journal of managed care & specialty pharmacy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.18553/jmcp.2020.26.1.16,
  title = {The Effectiveness and Value of Esketamine for the Management of Treatment-Resistant Depression.},
  author = {Agboola F and Atlas SJ and Touchette DR and Fazioli K and Pearson SD},
  year = {2020},
  journal = {Journal of managed care \& specialty pharmacy},
  doi = {10.18553/jmcp.2020.26.1.16},
  url = {https://doi.org/10.18553/jmcp.2020.26.1.16}
}

RIS

TY  - JOUR
TI  - The Effectiveness and Value of Esketamine for the Management of Treatment-Resistant Depression.
AU  - Agboola F
AU  - Atlas SJ
AU  - Touchette DR
AU  - Fazioli K
AU  - Pearson SD
PY  - 2020
JO  - Journal of managed care & specialty pharmacy
DO  - 10.18553/jmcp.2020.26.1.16
UR  - https://doi.org/10.18553/jmcp.2020.26.1.16
ER  - 

APA

F, A., SJ, A., DR, T., K, F., & SD, P. (2020). The Effectiveness and Value of Esketamine for the Management of Treatment-Resistant Depression.. Journal of managed care & specialty pharmacy. https://doi.org/10.18553/jmcp.2020.26.1.16

Source records